–
Inmune Bio, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions USD
FY21:
FY22:
–
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−29.2
FY22:
−26.0
FY23:
−29.7
FY24:
−42.6
FY25:
−47.4
(positive)
Change from FY21 to FY24
millions USD
FY21:
−29.2
FY22:
−26.0
FY23:
−29.7
FY24:
−42.6
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−30.3
FY22:
−27.3
FY23:
30.0
FY24:
42.1
FY25:
45.9
(positive)
Change from FY21 to FY25
millions USD
FY21:
−30.3
FY22:
−27.3
FY23:
−30.0
FY24:
−42.1
FY25:
−45.9
All amounts in millions USD